Victor Liu

Title: Victor Liu - Innovator in Cell Cryopreservation

Introduction

Victor Liu, an accomplished inventor based in Shanghai, China, has made significant contributions to the field of cell cryopreservation. With a total of two patents to his name, his innovative work has the potential to impact clinical applications in regenerative medicine and cell therapy.

Latest Patents

One of Victor Liu's latest patents is a cell freezing medium specifically designed for clinical use. This invention includes several key components: human albumin, a cryoprotectant composed of dimethyl sulfoxide, glycerol, and ethylene glycol, a saline buffer that features a mix of sodium, potassium, magnesium, chloride, and acetate ions, along with vitamins and amino acids. The concentration of human albumin in this medium is between 1% and 20% (w/v). The patented medium ensures high viability even after long-term cryopreservation, maintaining high cellular efficiency and uniformity. It is classified as pharmaceutical grade or USP grade, ensuring its reliability and safety for clinical application, suitable for both conventional adherent and suspension cells.

Career Highlights

Throughout his career, Victor Liu has worked with notable companies in the biotechnology sector, including Cellular Biomedicine Group (CBMG) and Abelzeta Inc. These experiences have allowed him to refine his expertise in the development of clinical-grade cell freezing mediums and other innovative biotechnological solutions.

Collaborations

Victor has had the opportunity to collaborate with esteemed colleagues, including Fei Wang and Dijun Zhao. Their joint efforts have enhanced the development of new technologies and approaches in the field, contributing to the advancement of cell preservation methods.

Conclusion

Victor Liu's innovative spirit and dedication to research in cell cryopreservation hold great promise for the future of clinical applications. His patented inventions reflect a commitment to improving the viability and efficiency of cryopreserved cells, positioning him as a notable figure in the biotech industry. As the demand for advanced cellular therapies grows, Victor's contributions will undoubtedly play a crucial role in this evolving landscape.